A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)

PHASE3RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

June 22, 2026

Study Completion Date

February 11, 2030

Conditions
Lung CancerNon-Small Cell Lung Cancer
Interventions
BIOLOGICAL

Pembrolizumab (+) Berahyaluronidase alfa

Administered subcutaneously on Day 1 of each cycle

BIOLOGICAL

Pembrolizumab

Administered intravenously on Day 1 of each cycle

Trial Locations (67)

8308

RECRUITING

Korea University Guro Hospital ( Site 3001), Seoul

10461

RECRUITING

Montefiore Medical Center ( Site 0104), The Bronx

13008

RECRUITING

Clínica San Antonio ( Site 1006), Trujillo

15036

RECRUITING

Clínica Internacional - Sede San Borja ( Site 1002), Lima

RECRUITING

IPOR Instituto Peruano de Oncología & Radioterapia ( Site 1004), Lima

RECRUITING

Oncosalud ( Site 1000), Lima

20014

RECRUITING

Onkologikoa - Instituto Oncologico de San Sebastian ( Site 2454), Donostia / San Sebastian

21005

RECRUITING

Hospital Universitario Juan Ramon Jimenez ( Site 2453), Huelva

34722

RECRUITING

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi ( Site 2506), Istanbul

35015

RECRUITING

Chungnam National University Hospital ( Site 3003), Daejeon

35100

RECRUITING

Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2501), Bornova

41009

RECRUITING

Hospital Universitario Virgen Macarena ( Site 2455), Seville

45219

RECRUITING

University of Cincinnati Medical Center ( Site 0112), Cincinnati

49241

RECRUITING

Pusan National University Hospital ( Site 3002), Pusan Kwangyokshi

61615

RECRUITING

Illinois Cancer Care ( Site 0101), Peoria

92835

RECRUITING

Providence Medical Foundation ( Site 0117), Fullerton

99089

RECRUITING

HELIOS Klinikum Erfurt ( Site 2005), Erfurt

100337

RECRUITING

Spitalul Municipal Schuller Ploiești ( Site 2204), Ploieşti

100730

RECRUITING

Beijing Peking Union Medical College Hospital ( Site 5000), Beijing

130000

RECRUITING

Jilin Province Tumor Hospital ( Site 5014), Changchun

200433

RECRUITING

Shanghai Pulmonary Hospital ( Site 5010), Shanghai

200746

RECRUITING

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 2201), Craiova

250013

RECRUITING

Jinan Central Hospital ( Site 5012), Jinan

310016

RECRUITING

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 5021), Hangzhou

317000

RECRUITING

Taizhou Hospital of Zhejiang Province ( Site 5002), Linhai

330006

RECRUITING

The First Affiliated Hospital of Nanchang University ( Site 5019), Nanchang

350014

RECRUITING

Fujian Province Cancer Hospital ( Site 5007), Fuzhou

361003

RECRUITING

The First Affiliated hospital of Xiamen University ( Site 5008), Xiamen

400015

RECRUITING

Institutul Oncologic ( Site 2202), Cluj-Napoca

404000

RECRUITING

Chongqing University Three Gorges Hospital ( Site 5018), Chongqing

407280

RECRUITING

SC Radiotherapy Center Cluj SRL ( Site 2203), Floreşti

430048

RECRUITING

Wuhan Union Hospital Cancer Center-Cancer Center ( Site 5015), Wuhan

510080

RECRUITING

The first affiliated hospital, Sun Yat-Sen university ( Site 5011), Guangzhou

510515

RECRUITING

Southern Medical University Nanfang Hospital ( Site 5003), Guangzhou

516001

RECRUITING

Huizhou Central People's Hospital ( Site 5004), Huizhou

529030

RECRUITING

Jiangmen Center Hospital ( Site 5001), Jiangmen

545006

RECRUITING

Liuzhou People's Hospital ( Site 5009), Liuzhou

610041

RECRUITING

West China Hospital of Sichuan University ( Site 5016), Chengdu

610213

RECRUITING

Sichuan Cancer Hospital. ( Site 5006), Chengdu

07747

RECRUITING

Universitätsklinikum Jena ( Site 2002), Jena

01009

RECRUITING

MEDI-K ( Site 1101), Guatemala City

01010

RECRUITING

CELAN,S.A ( Site 1104), Guatemala City

RECRUITING

Private Practice- Dr. Rixci Augusto Lenin Ramírez ( Site 1102), Guatemala City

09002

RECRUITING

Centro Medico Integral De Cancerología (CEMIC) ( Site 1103), Quetzaltenango

470-1192

RECRUITING

Fujita Health University Hospital ( Site 4004), Toyoake

791-0295

RECRUITING

Ehime University Hospital ( Site 4007), Tōon

807-8556

RECRUITING

Hospital of the University of Occupational and Environmental Health, Japan ( Site 4010), Kitakyushu

665-0827

RECRUITING

Takarazuka City Hospital ( Site 4006), Takarazuka

236-0051

RECRUITING

Kanagawa Cardiovascular and Respiratory Center ( Site 4002), Yokohama

783-8505

RECRUITING

Kochi Medical School Hospital ( Site 4012), Nankoku

981-1293

RECRUITING

Miyagi Cancer Center ( Site 4000), Natori-shi

591-8555

RECRUITING

National Hospital Organization Kinki-chuo Chest Medical Center ( Site 4009), Sakai

362-0806

RECRUITING

Saitama Prefectural Cancer Center ( Site 4001), Kitaadachi-gun

320-0834

RECRUITING

Tochigi Cancer Center ( Site 4008), Utsunomiya

113-8431

RECRUITING

Juntendo University Hospital ( Site 4003), Bunkyo

960-1295

RECRUITING

Fukushima Medical University Hospital ( Site 4011), Fukushima

541-8567

RECRUITING

Osaka International Cancer Institute ( Site 4005), Osaka

08-110

RECRUITING

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2305), Siedlce

02-781

RECRUITING

Narodowy Instytut Onkologii ( Site 2303), Warsaw

08035

RECRUITING

Hospital General Universitari Vall d Hebron ( Site 2450), Barcelona

08908

RECRUITING

INSTITUTO CATALAN DE ONCOLOGIA- L´HOSPITALET DE LLOBREGAT ( Site 2451), Barcelona

06010

RECRUITING

Gulhane Egitim Arastirma Hastanesi ( Site 2504), Ankara

06230

RECRUITING

Hacettepe Universite Hastaneleri-oncology hospital ( Site 2500), Ankara

06560

RECRUITING

Gazi University Health Research and Application Center Gazi Hospital-Oncology ( Site 2502), Ankara

06800

RECRUITING

Ankara Bilkent Sehir Hastanesi ( Site 2503), Ankara

TQ2 7AA

RECRUITING

Torbay Hospital ( Site 2100), Torquay

TR1 3LJ

RECRUITING

The Royal Cornwall Hospital ( Site 2102), Truro

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06698042 - A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84) | Biotech Hunter | Biotech Hunter